USP participates in a number of international harmonization initiatives to improve global public health through the development of high quality public standards. USP works with pharmacopoeias, the World Health Organization, and other stakeholders to determine optimal ways to advance and sustain globally harmonized standards. Learn More
Strengthening Global Medicines Quality: USP’s New Role in Harmonization
In the past three decades, an increasingly globalized medical marketplace has helped improve patient access to new medicines. Sadly, it has also provided an opportunity for more substandard, adulterated, and counterfeit medical products.
Pharmacopoeial Harmonization: Focus on Japan
While there are many pharmacopeias in the world, the goal of pharmacopeial harmonization is to achieve uniform public standards, which are truly representative of the global supply chain.
Pharmacopeial Meeting Highlights
Twice a year, USP, the Japanese Pharmacopoeia, and the European Pharmacopoeia convene to carry out the harmonization activities of the Pharmacopeial Discussion Group. Review highlights from the latest meetings.
Stage 4 Harmonization Notices
View the latest standards to enter the final stage of the harmonization process.
Stage 2 publications for public inquiry
View the latest Stage 2 Proposals published in Phamacopeial Forum (PF).
PDG working procedures changes
View implementation of significant changes to the Pharmacopeial Discussion Group work structure.